clinical progress of the entry inhibitor myrcludex b | stephan urban
Published 3 years ago • 687 plays • Length 17:36Download video MP4
Download video MP3
Similar videos
-
25:35
virological approach - entry inhibition | stephan urban, phd
-
1:34:11
dr. stephan urban: 2023 baruch s. blumberg prize recipient seminar
-
21:03
progress in hepatitis b cure research - peter revill
-
33:35
endpoints and new targets for curing hepatitis b | stephen locarnini
-
22:10
rationale for different virological targets in hbv | stephen locarnini, bsc(hons), phd, mbbs, frc
-
39:45
round table discussion: trial design, treatment endpoints and regulatory approach
-
20:46
strategy for the elimination of hepatitis b and c (academy of medicine report) | andrew aronsohn, md
-
6:01
a new hope for hepatitis b patients | bepirovirsen sodium | hepatitis b new treatment | gsk
-
4:57
hepatitis b symptoms, treatment and prevention
-
18:49
current treatment of hbv - anna lok
-
1:26:18
session 2
-
15:32
update on hepatitis delta therapy | robert gish md, faasld
-
22:18
why do we need new treatments and what is our definition of cure? | harry janssen, md, phd
-
2:28
bulevirtide (myrcludex-b, hepcludex) the mechanism of action
-
1:09
mayo clinic minute: hepatitis c epidemic
-
2:33
meet dr. oren fix: transplant hepatologist
-
0:31
nobel prize for discovery of hep-c virus
-
30:10
session 4 panel discussion
-
24:23
new treatment strategies for hepatitis b | harry janssen, md, phd
-
22:08
epidemiology of hepatitis b in central and eastern europe | adrian streinu cercel, md, phd
-
19:25
art: are two drugs enough? | mark boyd, ba, bm, bs, dcth&h, mhid, md, fracp
-
24:38
hepatitis delta: what are the new developments, what are the challenges? | cihan yurdaydin, md